Search Results - Mohr, P.

Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trial by Egberts, Friederike (Author) , Gutzmer, R. (Author) , Ugurel, S. (Author) , Becker, J. C. (Author) , Trefzer, U. (Author) , Degen, A. (Author) , Schenck, F. (Author) , Frey, L. (Author) , Wilhelm, T. (Author) , Hassel, Jessica C. (Author) , Schadendorf, D. (Author) , Livingstone, E. (Author) , Mauch, C. (Author) , Garbe, C. (Author) , Berking, C. (Author) , Rass, K. (Author) , Mohr, P. (Author) , Kaehler, K. C. (Author) , Weichenthal, M. (Author) , Hauschild, A. (Author) ,

• Verlag, lizenzpflichtig, Volltext
• Verlag, lizenzpflichtig, Volltext